ATG: Clinical Trials

14 trials of ATG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown, 5 completed, 1 terminated. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Unknown 8, Completed 5, Terminated 1

Follow ATG: new trials by email Literature Review of ATG trials Research Report on ATG

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation
Individual ATG, ATG - Hematopoietic Stem Cell Transplantation, Acute Leukemia
Phase 4UnknownThe First Affiliated Hospital of Soochow University902022-12-202023-02-15
ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis
ATG, CsA, MTX - Hematopoietic Stem Cell Transplantation
Phase 4UnknownNanfang Hospital, Southern Medical University2662019-09-012019-12-18
Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
Busulfan, Cyclophosphamide, Fludarabine - Thalassemia Major
Phase 4CompletedFirst Affiliated Hospital of Guangxi Medical University8232019-07-052024-08-09
PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis
ATG, CTX, Mycophenolate Mofetil - Hematopoietic Stem Cell Transplantation
Phase 4UnknownNanfang Hospital, Southern Medical University2602018-10-292019-10-28
ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center
ATG/PTCy, standard ATG, standard PTCy - Myeloid Tumor
Phase 4CompletedShanghai General Hospital, Shanghai Jiao Tong University School of Medicine4182018-07-282023-10-05
Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients
Anti-Tlymphocyte Globulins, Anti-Thymocyte Globulins - CKD (Chronic Kidney Disease) Stage 5T, Diabetes Mellitus
Phase 4UnknownTianjin First Central Hospital452018-03-012018-03-20
A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT
ATG - Chronic Graft-versus-host-disease, Leukemia Relapse
Phase 4UnknownZhujiang Hospital1922017-08-302017-06-19
Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major
Busulfan, Cyclophosphamide, Fludarabine - Thalassemia Major
Phase 4UnknownFirst Affiliated Hospital of Guangxi Medical University302017-04-012017-05-31
Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
ATG, CsA, mycophenolate mofetil - aGVHD
Phase 4CompletedChinese PLA General Hospital1002016-01-012022-05-24
Single Dose rATG for Renal Allograft Rejection
rATG - Acute (Cellular) Renal Allograft Rejection
Phase 4UnknownThe Methodist Hospital Research Institute302014-03-012020-09-03
ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis
ATG - Hematopoietic Stem Cell Transplantation, Antithymocyte Globulin
Phase 4CompletedNanfang Hospital, Southern Medical University4122013-06-012018-04-24
Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant
Everolimus, Very Low Tacrolimus, Low Tacrolimus - Transplantation Infection, Cytomegalovirus Infections
Phase 4CompletedRonaldo de Matos Esmeraldo, MD1202012-12-012019-02-22
De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction
rituximab and everolimus, thymoglobulin and tacrolimus - Renal Insufficiency
Phase 4TerminatedNational Taiwan University Hospital22011-04-012012-12-27
Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia
ATG - Severe Aplastic Anemia
Phase 4UnknownChinese Academy of Medical Sciences1002010-12-012013-12-03

Conditions studied

Graft vs Host Disease (2)  ·  Virus Diseases (2)  ·  beta-Thalassemia (2)  ·  Anemia, Aplastic (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cytomegalovirus Infections (1)  ·  Diabetes Mellitus (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Nanfang Hospital, Southern Medical University (3)  ·  First Affiliated Hospital of Guangxi Medical University (2)  ·  Chinese Academy of Medical Sciences (1)  ·  Chinese PLA General Hospital (1)  ·  National Taiwan University Hospital (1)  ·  Ronaldo de Matos Esmeraldo, MD (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  The Methodist Hospital Research Institute (1)  ·  Tianjin First Central Hospital (1)  ·  Zhujiang Hospital (1)

Countries

China (10)  ·  Brazil (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Qifa Liu (2)  ·  Yongrong Lai, MD (2)  ·  Bingyi Wu, MD (1)  ·  Daihong Liu, Doctor (1)  ·  MK Tsai, MD, PhD (1)  ·  Qifa Liu, MD (1)  ·  Ronaldo M Esmeraldo, MD (1)  ·  Samir Patel, PharmD (1)  ·  Xiaowen Tang, PhD (1)  ·  Yingxin FU, M.D (1)

Results publications

PMID 37341189, PMID 1090310, PMID 15814548, PMID 27855166, PMID 29969826, PMID 31401973, PMID 32164760, PMID 33663084, PMID 35467818, PMID 41730859, PMID 41849227